Zakharova, N.S., Britsyna, M.V., Mertsalova, N.U., Bazhanova, I.G., Ozeretskovskaya, M.N., Zaitsev, E.M., Pod-dubikov, A.V., Semenov, B.F.

Domestic acellular pertussis vaccine

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

Protective, immunogenic, toxic, and sensitizing properties of acellular pertussis vaccine (aPV) developed ac-cording to original technology were studied. aPV had marked protective activity which lasted more than 2 years. Sera of mice immunized by aPV also possess protective properties, and they were more prominent than in sera of mice immunized by pertussis bacteria suspension (PS). Immune sera to aPV neutralized cytopathogenic effect of pertussis toxin (PT) on ovarian Chinese hamster cells in 1:250 dilution, whereas neutralizing activity of sera to PS was very low. Level of antibodies to PT was higher in rabbits immunized, according to schedules and dosage recommended for children, by aPV than by PS. High immunogenicity of aPV was proved also by levels of IgG to PT in sera of mice immunized three times by aPV in human dosage. During experiments on mice and guinea pigs aPV had mild toxicity, did not induce autoimmune process, did not have anaphylactogenic properties compared with bacterial suspension characterized by high anaphylactogenic activity. Histamine-sensitizing ability of aPV was 40 times lower than that of PS. Assessment of pyrogenic properties of aPV and PS performed on rabbits showed that aPV was 1,000 times less pyrogenic than PS. Obtained results demonstrate high protective and im-munogenic properties of domestic acellular pertussis vaccine and its low toxic and sensitizing characteristics.
Zh. Mikrobiol. (Moscow), 2008, No. 1, P. 35—41